Parkash Singh Gill, MD

Title(s)Professor of Medicine
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 865 3909
vCardDownload vCard
    Other Positions
    Title(s)Renette and Marshall Ezralow Family Chair in Cancer Therapeutics

    Collapse Overview 
    Collapse Overview
    Dr. Gill's primary research interest is in studying novel targets that are expressed both in tumor blood vessels as well as the tumor cell. He has demonstrated the ability to identify and validate novel targets, develop novel target therapeutics and collaborate with clinical investigators to conduct early stage clinical trials.

    Dr. Gill has a strong history of clinical investigations and drug development. His clinical investigations led to the approval of three cancer drugs by the FDA. He also served on the advisory panel for the FDA advisory committee on biologics. Over the past several years his work has focused on the identification of novel cancer and cancer blood vessel targets, validation of the targets in various model systems including genetic mouse models.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
    NIH R01CA079218Jun 1, 1999 - Feb 28, 2011
    Role: Principal Investigator
    NIH R01HL048499May 1, 1992 - Jan 31, 1996
    Role: Principal Investigator
    NIH R01CA051621Sep 30, 1989 - Jul 31, 1995
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. EphrinB2: Expression of a novel potential target in renal cell carcinoma. Indian J Urol. 2023 Jul-Sep; 39(3):223-227. Gupta C, Sali AP, Jackovich A, Ma B, Sadeghi S, Quinn D, Gill P, Gill I. PMID: 37575160; PMCID: PMC10419785.
      View in: PubMed   Mentions:
    2. The Impact of Facility Surgical Caseload Volumes on Survival Outcomes in Patients Undergoing Radical Cystectomy. Cancers (Basel). 2022 Dec 03; 14(23). Cacciamani GE, Barzi A, Eppler MB, Lara PN, Pan CX, Bhanvadia SK, Gill P, Aron M, Gill I, Sadeghi S. PMID: 36497466; PMCID: PMC9735798.
      View in: PubMed   Mentions: 1  
    3. EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma. J Clin Oncol. 2023 01 20; 41(3):640-650. Sadeghi S, Quinn D, Dorff T, Pal S, Groshen S, Tsao-Wei D, Parikh R, Devitt M, Parikh M, Jackovich A, Ruel N, Vogelzang N, Burgess E, Siddiqi I, Gill IS, Lara PN, Dreicer R, Gill PS. PMID: 35984996.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    4. PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma. Front Immunol. 2021; 12:733136. Howard E, Hurrell BP, Helou DG, Quach C, Painter JD, Shafiei-Jahani P, Fung M, Gill PS, Soroosh P, Sharpe AH, Akbari O. PMID: 34531874; PMCID: PMC8438316.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    5. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. J Biol Chem. 2021 Jan-Jun; 296:100759. Carlos AJ, Ha DP, Yeh DW, Van Krieken R, Tseng CC, Zhang P, Gill P, Machida K, Lee AS. PMID: 33965375; PMCID: PMC8102082.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimalsCells
    6. Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways. Biol Open. 2021 02 25; 10(2). Li GX, Zhang S, Liu R, Singh B, Singh S, Quinn DI, Crump G, Gill PS. PMID: 32694189; PMCID: PMC7928229.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    7. Delta-like ligand 4-mediated Notch signaling controls proliferation of second heart field progenitor cells by regulating Fgf8 expression. Development. 2020 09 11; 147(17). De Zoysa P, Liu J, Toubat O, Choi J, Moon A, Gill PS, Duarte A, Sucov HM, Kumar SR. PMID: 32778568; PMCID: PMC7502602.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    8. Reply by Authors. J Urol. 2020 10; 204(4):660. Cacciamani GE, Ghodoussipour S, Mari A, Gill KS, Desai M, Artibani W, Gill PS, Shariat SF, Gill IS, Djaladat H. PMID: 32648804.
      View in: PubMed   Mentions:    Fields:    
    9. EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy. Pathol Res Pract. 2020 Jun; 216(6):152967. Gupta C, Sali A, Ma B, Jackovich A, Sadeghi S, Quinn D, Gill P, Gill I. PMID: 32362422; PMCID: PMC9084634.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis. J Urol. 2020 10; 204(4):649-660. Cacciamani GE, Ghodoussipour S, Mari A, Gill KS, Desai M, Artibani W, Gill PS, Shariat SF, Gill IS, Djaladat H. PMID: 32105187.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    11. Programmed Death 1 and Programmed Death Ligand 1 Inhibitors in Advanced and Recurrent Urothelial Carcinoma: Meta-analysis of Single-Agent Studies. Clin Genitourin Cancer. 2020 10; 18(5):351-360.e3. Tafuri A, Smith DD, Cacciamani GE, Cole S, Shakir A, Sadeghi S, Vogelzang NJ, Quinn D, Gill PS, Gill IS. PMID: 32146152; PMCID: PMC9135583.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer. Life Sci Alliance. 2019 08; 2(4). Tseng CC, Stanciauskas R, Zhang P, Woo D, Wu K, Kelly K, Gill PS, Yu M, Pinaud F, Lee AS. PMID: 31416894; PMCID: PMC6696983.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    13. Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer. J Urol. 2019 02; 201(2):332-341. Rajarubendra N, Almeida F, Manojlovic Z, Ohe C, Ahmadi N, Cacciamani G, Qiu M, Abreu A, Cai J, Miranda G, Stern MC, Carpten J, Kuhn P, Amin MB, Gill PS, Aron M, Gill IS. PMID: 30218760; PMCID: PMC9504582.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Adv. 2017 Sep 12; 1(20):1635-1644. Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche TJ, Druker BJ, Tyner JW, Gill PS. PMID: 29296810; PMCID: PMC5728330.
      View in: PubMed   Mentions: 10     Fields:    
    15. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice. Proc Natl Acad Sci U S A. 2017 05 16; 114(20):E4020-E4029. Shen J, Ha DP, Zhu G, Rangel DF, Kobielak A, Gill PS, Groshen S, Dubeau L, Lee AS. PMID: 28461470; PMCID: PMC5441757.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    16. Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series. BJU Int. 2017 09; 120(3):401-408. Abreu A, Fay C, Park D, Quinn D, Dorff T, Carpten J, Kuhn P, Gill P, Almeida F, Gill I. PMID: 27981731; PMCID: PMC9084626.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    17. Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome Biol. 2017 01 12; 18(1):3. Mundbjerg K, Chopra S, Alemozaffar M, Duymich C, Lakshminarasimhan R, Nichols PW, Aron M, Siegmund KD, Ukimura O, Aron M, Stern M, Gill P, Carpten JD, Ørntoft TF, Sørensen KD, Weisenberger DJ, Jones PA, Duddalwar V, Gill I, Liang G. PMID: 28081708; PMCID: PMC5234101.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    18. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. Br J Cancer. 2015 Aug 11; 113(4):616-25. Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS. PMID: 26180925; PMCID: PMC4647683.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    19. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Oct; 34(43):5418-26. Lin YG, Shen J, Yoo E, Liu R, Yen HY, Mehta A, Rajaei A, Yang W, Mhawech-Fauceglia P, DeMayo FJ, Lydon J, Gill P, Lee AS. PMID: 25684138; PMCID: PMC4537850.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    20. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. PMID: 25148033; PMCID: PMC4141800.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    21. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 24424460; PMCID: PMC4183751.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    22. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. PMID: 24978094; PMCID: PMC4224514.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    23. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. PMID: 24048331; PMCID: PMC4151476.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    24. EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269. Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. PMID: 23721559; PMCID: PMC3671960.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    25. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23667241.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    26. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PMID: 23211050; PMCID: PMC3540204.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    27. Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochem Biophys Res Commun. 2012 Feb 03; 418(1):173-9. Liu R, Trindade A, Sun Z, Kumar R, Weaver FA, Krasnoperov V, Naga K, Duarte A, Gill PS. PMID: 22252294.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    28. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer. 2010 Nov 23; 10:641. Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. PMID: 21092311; PMCID: PMC3001720.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    29. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 2010 Sep; 5(9):1349-65. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. PMID: 20860481; PMCID: PMC3076960.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    30. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. PMID: 20442363; PMCID: PMC2910613.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    31. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem. 2010 May 14; 285(20):15065-15075. Zhang Y, Liu R, Ni M, Gill P, Lee AS. PMID: 20208072; PMCID: PMC2865300.
      View in: PubMed   Mentions: 166     Fields:    Translation:HumansCells
    32. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. PMID: 19965636; PMCID: PMC2815507.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    33. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci. 2010 Jan; 51(1):543-52. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. PMID: 19696168; PMCID: PMC2828363.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    34. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res. 2009 May 01; 69(9):3736-45. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. PMID: 19366806.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    35. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2009 Jan 01; 113(1):254-63. Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS. PMID: 18836096; PMCID: PMC2614637.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    36. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008 Sep; 134(9):985-91. Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R. PMID: 18794445.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    37. Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood. 2008 Apr 01; 111(7):3377-82. Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM. PMID: 18077789; PMCID: PMC2275007.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    38. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res. 2007 Apr; 5(4):351-62. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. PMID: 17426250.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    39. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 Apr 10; 96(7):1083-91. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. PMID: 17353927; PMCID: PMC2360128.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    40. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007 Jun 01; 109(11):4753-60. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. PMID: 17311993; PMCID: PMC1885521.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansAnimalsCells
    41. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1053-9. Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS. PMID: 17043250.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    42. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer. 2006 Sep 15; 119(6):1236-48. Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS. PMID: 16615113.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    43. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006 Jul; 169(1):279-93. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. PMID: 16816380; PMCID: PMC1698769.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimalsCells
    44. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol. 2006 Apr; 175(4):1245-52. Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. PMID: 16515971.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    45. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. PMID: 16520466.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    46. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006 Feb 02; 25(5):769-80. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, Hassanieh L, Smith DL, Buscarini M, Broek D, Quinn DI, Weaver FA, Gill PS. PMID: 16205642.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    47. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4772-9. He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR. PMID: 16303978.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    48. Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005 Jun 15; 11(12):4305-15. Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS. PMID: 15958611.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    49. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 01; 65(11):4623-32. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. PMID: 15930280.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    50. Molecular prognostic factors in bladder cancer. BJU Int. 2005 Apr; 95(6):739-42. Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP. PMID: 15794774.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol. 2004 Nov; 24(6):617-22. Cozen W, Diaz-Sanchez D, James Gauderman W, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM. PMID: 15622446.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    52. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 01; 105(3):1310-8. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. PMID: 15471957.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    53. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004 Apr 15; 103(8):3216-21. Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, Mack TM. PMID: 15070705.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    54. Expression of EphB4 in head and neck squamous cell carcinoma. Ear Nose Throat J. 2003 Nov; 82(11):866, 869-70, 887. Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS. PMID: 14661437.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    55. Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan. Int J Cancer. 2003 Sep 10; 106(4):528-533. Smith DL, Cai J, Zhu S, Wei W, Fukumoto J, Sharma S, Masood R, Gill PS. PMID: 12845648.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    56. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer. 2003 May 01; 104(5):603-10. Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS. PMID: 12594815.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    57. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 01; 95(1):147-54. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. PMID: 12115328.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    58. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. PMID: 11755462.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    59. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol. 2002 Jan; 160(1):23-9. Masood R, Cesarman E, Smith DL, Gill PS, Flore O. PMID: 11786394; PMCID: PMC1867113.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    60. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. Int J Mol Med. 2001 Oct; 8(4):335-43. Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. PMID: 11562769.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    61. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. PMID: 11555581.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    62. Results of a collaborative study of the EDNAP group regarding the reproducibility and robustness of the Y-chromosome STRs DYS19, DYS389 I and II, DYS390 and DYS393 in a PCR pentaplex format. Forensic Sci Int. 2001 Jun 01; 119(1):28-41. Carracedo A, Beckmann A, Bengs A, Brinkmann B, Caglia A, Capelli C, Gill P, Gusmão L, Hagelberg C, Hohoff C, Hoste B, Kihlgren A, Kloosterman A, Myhre Dupuy B, Morling N, O'Donnell G, Parson W, Phillips C, Pouwels M, Scheithauer R, Schmitter H, Schneider PM, Schumm J, Skitsa I, Stradmann-Bellinghausen B, Stuart M, Syndercombe Court D, Vide C. PMID: 11348791.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    63. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. PMID: 11110677.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    64. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 01; 96(9):3188-94. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. PMID: 11050002.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    65. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. PMID: 10673512.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    66. Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells. Sarcoma. 2000; 4(1-2):37-45. Cai J, Zheng T, Masood R, Smith DL, Hinton DR, Kim CN, Fang G, Bhalla K, Gill PS. PMID: 18521433; PMCID: PMC2408359.
      View in: PubMed   Mentions: 4  
    67. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999 Jul 01; 94(1):275-82. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. PMID: 10381523.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    68. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. PMID: 10561228.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    69. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood. 1999 Feb 01; 93(3):1038-44. Masood R, McGarvey ME, Zheng T, Cai J, Arora N, Smith DL, Sloane N, Gill PS. PMID: 9920854.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    70. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. PMID: 9779714.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    71. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. PMID: 9800111.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    72. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 07; 95(14):8257-61. Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WA, Cheung T, Nathwani B, Jones PA. PMID: 9653174; PMCID: PMC20963.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    73. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum. 1998 Jan-Feb; 25(1):67-70. Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS. PMID: 9460774.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    74. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 03; 89(23):1797-802. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. PMID: 9392621.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    75. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Cancer J Sci Am. 1997 Sep-Oct; 3(5):278-83. Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA. PMID: 9327151.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    76. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. PMID: 9327221.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    77. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood. 1997 Mar 01; 89(5):1491-500. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. PMID: 9057628.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    78. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 04; 94(3):979-84. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. PMID: 9023368; PMCID: PMC19625.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    79. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. PMID: 9093711.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    80. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Invest New Drugs. 1997; 15(4):279-87. Cai J, Zheng T, Murphy J, Waters CA, Lin GY, Gill PS. PMID: 9547670.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    81. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. PMID: 8857005.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    82. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 01; 78(3):517-26. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. PMID: 8697399.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    83. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug; 14(8):2353-64. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. PMID: 8708728.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    84. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma. Int J Radiat Biol. 1995 Oct; 68(4):411-2. Formenti SC, Chak L, Gill P, Buess EM, Hill CK. PMID: 7594966.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    85. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26):1744-8. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, et al. PMID: 7760890.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    86. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):455-60. Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P. PMID: 7697441.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    87. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. PMID: 7707129.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    88. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1994 Dec; 8(12):1695-9. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. PMID: 7534090.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    89. An unusual case of metastatic intracardiac plasmacytoma. Can J Cardiol. 1994 Oct; 10(8):857-60. Tak T, Rashtian M, De Tar M, Chandraratna PA, Gill P. PMID: 7954022.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    90. Extramedullary plasmacytoma of the heart presenting as cardiac emergency. Review of literature. Am J Clin Oncol. 1994 Oct; 17(5):427-9. Keung YK, Lau S, Gill P. PMID: 8092116.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    91. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses. 1994 Aug; 10(8):969-75. Masood R, Lunardi-Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. PMID: 7811548.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    92. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994 Jul 15; 202(1):374-83. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS. PMID: 8037735.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    93. Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol. 1994 Jul; 112(7):954-9. Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA. PMID: 8031276.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    94. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol. 1994 Jul; 145(1):74-9. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka SF. PMID: 8030759; PMCID: PMC1887313.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    95. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J Acquir Immune Defic Syndr (1988). 1994 Apr; 7(4):410-4. Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. PMID: 7907664.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    96. Solid tumor treatment workshop summary. Leukemia. 1994; 8 Suppl 3:S83-4. Gill PS, Parkinson D. PMID: 7808033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. PMID: 7808021.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    98. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses. 1993 Aug; 9(8):741-6. Masood R, Husain SR, Rahman A, Gill P. PMID: 8217343.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    99. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1992 Dec; 6(12):1477-81. Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomery T, Berry MS, Levine A. PMID: 1283520.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    100. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology. 1992 Jul; 99(7):1127-32. Dugel PU, Gill PS, Frangieh GT, Rao NA. PMID: 1495793.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    101. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens. Semin Oncol. 1992 Apr; 19(2 Suppl 5):32-6; discussion 36-7. Ireland-Gill A, Espina BM, Akil B, Gill PS. PMID: 1384142.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    102. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol. 1991 Dec; 38(4):261-6. Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. PMID: 1746533.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    103. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Semin Oncol. 1991 Oct; 18(5 Suppl 7):53-7. Gill PS. PMID: 1719642.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    104. Pathogenesis of HIV-related malignancies. Curr Opin Oncol. 1991 Oct; 3(5):867-71. Gill PS. PMID: 1751580.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    105. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med. 1991 Apr; 90(4):427-33. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M, et al. PMID: 1707230.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    106. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr (1988). 1991; 4(6):593-7. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. PMID: 1673713.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    107. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1990 Dec; 2(6):1161-6. Gill PS, Naidu YM, Salahuddin SZ. PMID: 2099846.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Biol Response Mod. 1990 Oct; 9(5):512-6. Gill PS, Rarick MU, Bernstein-Singer M, Espina BM, Jones B, Montgomery T, Sharma D, Rasheed S, Levine AM. PMID: 2254762.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    109. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol. 1990 Aug; 13(4):315-9. Gill P, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, Levine A. PMID: 1696066.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    110. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol. 1990 Aug; 85(8):959-61. Laine L, Amerian J, Rarick M, Harb M, Gill PS. PMID: 1695812.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer. 1990 Mar 01; 65(5):1074-8. Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, Levine AM. PMID: 1689209.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    112. Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol. 1990; 1(2):147-9. Rarick MU, Gill PS, Montgomery T, Bernstein-Singer M, Jones B, Levine AM. PMID: 1706615.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    113. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med. 1989 Dec 01; 111(11):871-5. Shibata D, Brynes RK, Rabinowitz A, Hanson CA, Slovak ML, Spira TJ, Gill P. PMID: 2573306.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    114. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1989 Oct; 1(1):57-61. Gill PS, Brynes R. PMID: 2489949.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    115. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med. 1989 Jul; 87(1):57-61. Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. PMID: 2472743.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    116. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Jun 01; 110(11):937-40. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. PMID: 2719427.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    117. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 1989 Mar 15; 63(6):1101-7. Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W, Petrovich Z, Chak L, Levine AM. PMID: 2917314.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    118. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989 Jan; 73(1):235-9. Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR. PMID: 2910361.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    119. Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report. Artif Organs. 1988 Dec; 12(6):484-90. Bertram JH, Snyder HW, Gill PS, Shulman I, Henry DH, Jenkins D, Kiprov DD. PMID: 3063241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med. 1988 Sep; 112(9):898-900. Jamin D, Shulman I, Lam HT, Aguilar S, Shields M, Cohen J, Gill P, Levine A. PMID: 3415441.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    121. Autopsy findings in AIDS-related lymphoma. Cancer. 1988 Aug 15; 62(4):735-9. Loureiro C, Gill PS, Meyer PR, Rhodes R, Rarick MU, Levine AM. PMID: 3395957.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    122. Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center. J Clin Oncol. 1988 Aug; 6(8):1285-92. Hu E, Hufford S, Lukes R, Bernstein-Singer M, Sobel G, Gill P, Pinter-Brown L, Rarick M, Rosen P, Brynes R, et al. PMID: 3411341.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol. 1988 May; 6(5):863-7. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. PMID: 3367189.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    124. HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. Cancer Invest. 1988; 6(4):413-6. Gill PS, Levine AM. PMID: 3179773.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    125. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging. 1986; 1(3):134-41. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine AM. PMID: 3451758.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Parkash's Networks
    Concepts (589)
    Derived automatically from this person's publications.
    Co-Authors (57)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department